HYBRID EVENT: Join us in person in Orlando, Florida, USA or attend virtually from anywhere.

8th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2027 | Orlando, Florida, USA

Endocannabinoid System Dysregulation in Addiction

Endocannabinoid System Dysregulation in Addiction

The endocannabinoid system (ECS) is vital in maintaining emotional balance, stress regulation, and reward processing. Chronic substance use disrupts this system, altering the function of cannabinoid receptors and the production of endocannabinoids. For example, excessive cannabis use desensitizes the CB1 receptor, leading to reduced natural reward responses and increased cravings. Similarly, other substances indirectly affect the ECS by impairing its interaction with neurotransmitter systems. This dysregulation contributes to withdrawal symptoms, heightened stress sensitivity, and difficulty sustaining sobriety. Emerging therapies aim to restore ECS function using receptor modulators, dietary changes, and physical activities that promote endocannabinoid balance. Understanding the ECS’s role in addiction provides a promising direction for personalized treatments that target the biological underpinnings of dependency. Such interventions can improve emotional stability, reduce relapse rates, and support long-term recovery.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Christopher Ashton

Christopher Ashton

TeDDs on Chapel, Centre for Recovery, Canada
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - John J Giordano

John J Giordano

Life Enhancement Recovery Center, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Sam Vaknin

Sam Vaknin

Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
Tags

Submit your abstract Today

Whatsapp